DALI PHARMACEUTICALCO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.1 CNY | +2.40% |
|
-5.81% | -31.82% |
| Sales 2022 | 132M 18.26M 1.46B | Sales 2023 | 87.27M 12.04M 965M | Capitalization | 2.61B 360M 28.85B |
|---|---|---|---|---|---|
| Net income 2022 | -17M -2.35M -188M | Net income 2023 | -20M -2.76M -221M | EV / Sales 2022 | 20 x |
| Net cash position 2022 | 228M 31.45M 2.52B | Net cash position 2023 | 197M 27.22M 2.18B | EV / Sales 2023 | 27.6 x |
| P/E ratio 2022 |
-163
x | P/E ratio 2023 |
-132
x | Employees | 289 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 28.94% |
More Fundamentals
* Assessed data
More news
| 1 day | +2.40% | ||
| 1 week | -5.81% | ||
| Current month | -27.22% | ||
| 1 month | -30.41% | ||
| 3 months | -22.56% | ||
| 6 months | -20.59% | ||
| Current year | -31.82% |
1 week
7.24
8.50
1 month
6.8012.81
Current year
5.2415.97
1 year
5.2415.97
3 years
5.2420.22
5 years
5.2420.22
10 years
5.2421.38
| Managers | Title | Age | Since |
|---|---|---|---|
Jun Xiang Yang
CEO | Chief Executive Officer | 61 | 20/10/96 |
Shao Yun Li
DFI | Director of Finance/CFO | 55 | 30/06/98 |
Wei Yuan
BRD | Director/Board Member | 54 | 30/06/14 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ji Yao Zeng
BRD | Director/Board Member | 79 | 28/06/15 |
Jun Xiang Yang
CEO | Chief Executive Officer | 61 | 20/10/96 |
Li Hua Zeng
BRD | Director/Board Member | 53 | 27/07/14 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/04/24 | 8.1 | +2.40% | 13,489,810 |
| 24/04/24 | 7.91 | +1.15% | 11,584,920 |
| 23/04/24 | 7.82 | +0.64% | 10,566,560 |
| 22/04/24 | 7.77 | -9.65% | 16,527,930 |
| 19/04/24 | 8.6 | +4.62% | 17,551,910 |
End-of-day quote Shanghai S.E., April 24, 2024
More quotes
Dali Pharmaceutical Co Ltd is a China-based company principally involved in the production and sales of Chinese and western medicine injections. The Companyâs main products include Xingnaojing injections and Shenmai injections. The other products include astragalus injections and mycorrhizal injections. Through its subsidiaries, the Company is also involved in the lease of offices and factory buildings, as well as the investment of equity.
Sector
Pharmaceuticals
Calendar
20/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -31.82% | 246M | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
- Stock Market
- Equities
- 603963 Stock
